Complete Wegovy And Mounjaro Doses Comparison Guide
Private Prescription Advantages For Wegovy And Mounjaro Doses
Accessing Wegovy and Mounjaro doses through private prescription eliminates the frustrating NHS pathway of GP referrals, specialist weight management service waiting lists, and strict eligibility criteria that can delay treatment for months. Private prescription allows you to begin your weight management journey immediately following a clinical assessment, with both medications available through our GPhC-registered pharmacy (#9012878). Unlike NHS routes that may restrict dosing flexibility, private prescription enables personalised dose escalation schedules tailored to your tolerance and response. This approach ensures you receive the optimal Wegovy and Mounjaro doses for your individual circumstances without bureaucratic delays.
The private route also provides greater medication choice, as you're not limited by local NHS formulary restrictions that might favour one treatment over another. Our prescribers can objectively assess whether Wegovy's GLP-1-only mechanism or Mounjaro's dual GIP+GLP-1 approach better suits your medical profile and weight management goals. This personalised approach to Wegovy and Mounjaro doses selection, combined with ongoing prescriber support throughout your treatment journey, represents a significant advantage over the often fragmented NHS weight management pathway. Additionally, private prescription ensures consistent supply continuity, eliminating concerns about NHS stock shortages or prescription delays.
Wegovy And Mounjaro Doses Pricing Structure
Understanding the cost of Wegovy and Mounjaro doses helps you plan your private weight management investment effectively. Wegovy follows a structured escalation from £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to the maintenance 2.4mg dose at £209.99. New customers receive discount code FIRST40, while returning patients use DOSE25, applied at checkout to reach these final prices. Our bundle options provide convenient multi-month supplies, such as the Intro Trio covering your first three Wegovy and Mounjaro doses escalation steps for £299.99. This transparent pricing structure allows you to budget accurately for your complete treatment course without hidden fees or surprise costs.
Mounjaro pricing follows a similar escalation pattern, though the dual hormone mechanism often requires different dose adjustment timings compared to Wegovy's weekly increases. Both medications qualify for the same discount codes, ensuring equitable pricing regardless of which option your prescriber recommends for your specific needs. Our 2-pen bundles offer supply security, particularly valuable during the initial Wegovy and Mounjaro doses escalation phase when consistent progression is crucial for tolerability. The Ultimate Stability Trio provides three months of maintenance supply at £649.99, ideal for patients established on their optimal dose who want to ensure uninterrupted treatment continuity.
Clinical Evidence Behind Wegovy And Mounjaro Doses
The STEP trial programme established Wegovy's efficacy profile across its dose range, with the landmark STEP 1 study demonstrating approximately 15% average weight loss at 68 weeks versus 2.4% with placebo when used alongside diet and exercise (Wilding et al., NEJM, 2021). These trials validated the current Wegovy and Mounjaro doses escalation protocol, showing that gradual dose increases maximise efficacy while minimising gastrointestinal side effects. The STEP 5 extension demonstrated sustained weight loss of approximately 15.2% at two years, confirming long-term effectiveness of the maintenance dosing strategy.
Mounjaro's clinical evidence from the SURMOUNT trials showcases the dual GIP+GLP-1 mechanism's potential, though direct head-to-head comparisons between Wegovy and Mounjaro doses aren't available due to different trial designs and patient populations. Both medications demonstrated cardiovascular benefits in their respective outcome studies, with Wegovy's SELECT trial showing 20% reduction in major cardiovascular events. Clinical evidence consistently supports the gradual dose escalation approach used for both medications, as this protocol optimises patient tolerability while achieving maximum therapeutic benefit.
How Wegovy Works Compared To Mounjaro Mechanisms
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. This single-hormone approach targets specific brain centres controlling food intake, helping you feel satisfied with smaller portions and reducing food cravings between meals. Mounjaro uses tirzepatide, a dual hormone agonist targeting both GIP and GLP-1 receptors, potentially offering enhanced glucose control alongside appetite regulation. The choice between these Wegovy and Mounjaro doses mechanisms depends on your individual metabolic profile, diabetes status, and treatment goals. Both medications require weekly injection using pre-filled FlexTouch pens, making administration convenient regardless of which option your prescriber selects for your needs.
Streamlined Ordering Process For Both Medications
Obtaining Wegovy and Mounjaro doses through EverydayMeds begins with our comprehensive 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and lifestyle factors. Our prescribers review applications within 3 working days (express 24-hour service available), ensuring thorough evaluation before recommending the most suitable medication and starting dose for your circumstances. Once approved, your prescription-only medicine ships via next-day cold-chain delivery, maintaining the 2-8°C temperature requirement throughout transit to preserve medication efficacy. This streamlined process eliminates the typical NHS delays while maintaining full clinical oversight and safety protocols. Our pharmacy team coordinates directly with prescribers for any dose adjustments or medication switches needed during your treatment journey.
Storage Advantages And Practical Considerations
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable for 6 weeks at room temperature below 30°C once removed from refrigeration, while Mounjaro requires return to cold storage after 21 days. This storage advantage makes Wegovy and Mounjaro doses management easier for frequent travellers or those with limited refrigerator space during the summer months. Both medications use the FlexTouch pen system for consistent, accurate dosing, with clear dosage windows to confirm proper administration. The mandatory dose escalation schedule for both medications requires careful planning, as skipping doses or escalating too quickly can compromise both safety and effectiveness. Our pharmacy provides detailed storage instructions and escalation schedules with each delivery, ensuring you understand the precise requirements for your chosen medication.
Comparing Wegovy And Mounjaro Doses For Different Patient Profiles
Patients with type 2 diabetes may benefit from Mounjaro's enhanced glucose-lowering effects through its dual hormone mechanism, while those focused primarily on appetite control might find Wegovy's targeted GLP-1 approach sufficient for their needs. The choice between Wegovy and Mounjaro doses often depends on your existing medications, as some combinations work better with single-hormone versus dual-hormone approaches. Patients with gastroparesis or significant gastrointestinal conditions may require different escalation schedules, making prescriber expertise crucial in optimising your treatment plan.
Age, baseline BMI, and previous weight loss attempts also influence medication selection, as some patients respond better to the more intensive dual-hormone stimulation while others achieve excellent results with Wegovy's established mechanism. Our prescribers consider these individual factors when recommending between Wegovy and Mounjaro doses, ensuring your treatment choice aligns with your medical profile and realistic expectations. Both medications require long-term commitment, as clinical trials show patients typically regain approximately two-thirds of lost weight within one year of stopping treatment.
Start Your Weight Management Journey Today
Both Wegovy and Mounjaro represent clinically-proven options for weight management when used alongside a reduced-calorie diet and increased physical activity, with your EverydayMeds prescriber helping determine which medication best suits your individual needs. Our transparent pricing, starting from £79.99 for initial Wegovy doses, includes ongoing prescriber support throughout your treatment journey. Use discount code FIRST40 for new customers or DOSE25 for returning patients at checkout to access these competitive prices. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment today and take the first step toward effective weight management. Remember that both medications are prescription-only medicines requiring professional oversight, ensuring your safety while maximising treatment success through our comprehensive care approach.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
